WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics […]
Scalable collaboration for biotech and pharma teams: Enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing Integrated, AI-ready biologics ecosystem: Connects design to execution through native Signals One platform integration and cloud-native infrastructure Unified molecular cloning workflows: Supports Golden Gate, Gibson assembly, restriction/ligation, primer design, and sequencing analysis in one platform WALTHAM, […]
The collaboration pairs Mimulus’s molecular architecture with GenScript’s massive synthesis scale to liberate critical grid power for AI compute and launch the “Forever Archive” for enterprise data permanence. LOS ANGELES and PISCATAWAY, N.J. — Mimulus Corp, the pioneer in Molecular Archive Technology™, and GenScript Biotech Corporation, the world’s leading provider of CMOS-based DNA synthesis technologies, today announced […]
Engineered for high-performance workflows, the kits support rare mutation detection, small RNA profiling and multimodal analysis INDIANAPOLIS – Beckman Coulter Life Sciences—a Danaher business and a global leader in research laboratory instruments, automation and genomic solutions—announces expanded distribution of Apostle MiniMax® High-Efficiency Isolation Kits for cfDNA, cfRNA and total cfNA extraction. Developed by Apostle Inc., […]
Rapid preselection of high-producing clones from candidate pools, saving resources Monoclonality verification with automated documentation for full traceability Up to 100 percent transfer efficiency and viability to protect top clones for downstream expansion Göttingen, Germany — Sartorius announces the launch of the CellCelector CLD, an automated imaging and cell isolation platform designed to simplify and accelerate […]
Former Biosynth CEO and life sciences investor brings scale-up, operational, and governance experience as Ribbon advances its cell-free DNA platform VIENNA — Cell-Free DNA Assembly pioneer, Ribbon Bio, has today announced the appointment of Dr. Urs Spitz as Chair of its Board of Directors. Dr. Spitz brings nearly three decades of experience founding, scaling, and governing life […]
Partnership Delivers RoosterBio’s Research-Grade and CliniControl™ cGMP Media Platforms to China’s Leading Cell and Gene Therapy Developers; MineBio Holds Import Approval for Immediate Order Fulfillment FREDERICK, MD. — RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioprocess media, and advanced therapy manufacturing solutions for hMSCs and exosomes, today announced an […]
CTL adds analyzers, software, consumables, and services at a workflow-critical measurement layer across translational and clinical research SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building differentiated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Cellular Technology Limited (“CTL”), a provider of functional immune […]
CAMBRIDGE, Mass. and SAN FRANCISCO, Calif. – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate Kytopen’s global commercial expansion and drive further adoption of its Flowfect® technology platform across the U.S. and Europe. […]
TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom — TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
